 
                  
India may resume the export of COVID-19 vaccines by the end of the year: SII CEO Adar Poonawalla
Serum Institute of India (SII) CEO Adar Poonawalla stated that India may resume the export of COVID-19 vaccines by the end of the year.
Stay updated with the latest news and articles about covid vaccines.
 
                  
Serum Institute of India (SII) CEO Adar Poonawalla stated that India may resume the export of COVID-19 vaccines by the end of the year.
 
                  
The statement added that it was an important milestone that has paved the way to bring the company’s single-dose COVID-19 vaccine to the people of India and for the rest of the world with a collaboration with Biological E Limited.
 
                  
In the mission, clinical trial lot manufacturing of promising vaccine candidates which include the DNA vaccine candidate; ZydusCadila, mRNA vaccine candidate; Gennova Biopharmaceuticals, and Intanasal vaccine candidate; Bharat Biotech, were being supported.
 
                  
In the study, the researchers who were working to know the feasibility of using a different vaccine doss for the prime vaccination than the one used for the booster vaccination, discovered that mixing the doses of two different vaccines could generate stronger immunity.
 
                  
The Brazil Health Minister, Marcelo Queiroga, on Wednesday, announced that the company had temporarily suspended its deal with the Hyderabad based pharmaceutical company following allegations of irregularities in the deal.
 
                  
Russia would import the first 50 million jabs ensuring a speedier rollout before the Indian pharmaceuticals company’s start producing the Sputnik V vaccines.
 
                  
In the previous one week, India had administered over 3 crore, 91 lakh vaccine doses. The Health Ministry in a tweet said that the milestone vaccination figure outnumbered the population of many countries like Canada, Malaysia and Saudi Arabia.
 
                  
Pfizer vaccine could be available in India by August as per the speculations. Pfizer however has not issued any official statement for the same. The Government had accepted one of the conditions of the company already, to do away with trials on the local population.
Showing 15 of 150,339 articles
